Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel natural inhibitors targeting KRAS G12C by computational study.

Anti-cancer drugs - 1 Oct 2022

Jiang Yuting, Chen Wanting, Wang Xinhui, Zhou Baolin, Xie Haoqun, Hou Yuanyuan, Guo Zhen, Yu Bo, Zhong Sheng, Su Xing

Abstract excerpt

Ideal leading and nominee compounds with inhibiting effects on KRAS G12C were selected from the ZINC database, laying a cornerstone for the progress of anticancer drugs. A variety of computational virtual screening methods were utilized to screen possible inhibitors of KRAS G12C. LibDock was utilized to estimate 17 930 compounds and the top 20 were nominated for additional study, which was absorption,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Cytochrome P-450 CYP2D6

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Docking Simulation

Share to Mutation

Share to Proto-Oncogene Proteins p21(ras)

Source

Identifiers

PMID: 35980001
DOI: 10.1097/CAD.0000000000001317

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel natural inhibitors targeting KRAS G12C by computational study.PMID 35980001Read ↗

Computational study of novel natural inhibitors targeting Kirsten rat sarcoma viral oncogene homolog G12C.Semantic proximity Read ↗

The inhibitory effect of common food spices bioactive compounds against KRAS G12C and KRAS G12D: an in-silico approachSemantic proximity Read ↗

Structure-Based Virtual Screening for Novel Inhibitors Targeting KRAS G12C.Semantic proximity Read ↗

Drug Repurposing against KRAS Mutant G12C: A Machine Learning, Molecular Docking, and Molecular Dynamics Study.Semantic proximity Read ↗

Recent advances in the development of inhibitors targeting KRAS-G12C and its related pathways.Semantic proximity Read ↗

KRAS G12D can be targeted by potent salt-bridge forming inhibitorsSemantic proximity Read ↗

Multiple initiatives to conquer KRAS G12C inhibitor resistance from the perspective of clinical therapy.Semantic proximity Read ↗

New Natural Compound Inhibitors of Checkpoint Kinase-1(CHK1) Based on Computational StudySemantic proximity Read ↗

Computationally Empowered Workflow Identifies Novel Covalent Allosteric Binders for KRASG12C.Semantic proximity Read ↗

Multiple Strategies to Develop Small Molecular KRAS Directly Bound Inhibitors.Semantic proximity Read ↗

The Research Progress of Direct KRAS G12C Mutation Inhibitors.Semantic proximity Read ↗

The KRASG12D Inhibitor Pipeline Grows.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.